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ELECTRONIC LETTER
Prevalence of family histories of breast cancer in the
general population and the incidence of related seeking
of health care
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Breast cancer is the most widespread cancer in women inwestern countries, currently accounting for one third ofall cancers in women.1 2 The lifetime risk of developing
breast cancer is 9% in the United Kingdom,3 10% in The
Netherlands,1 and 12% in the United States.4 About 15%–20%
of all cases of breast cancer are thought to be familial,5 6 and
about 5%–10% of all breast cancers are attributed to the
known breast cancer susceptibility genes BRCA1 and
BRCA2.7–9
In most European countries nationwide breast cancer
screening programmes are available for women of 50 years
and older,10 whereas comprehensive screening for breast can-
cer in women under the age of 50 has been found cost ineffec-
tive. It is widely acknowledged that women who have relatives
with breast cancer have an increased risk of developing breast
cancer themselves.11 12 Consequently, screening for breast can-
cer might be advisable and cost effective in the subgroup of
women under the age of 50 with a familial predisposition to
breast cancer. We therefore started a study on the cost
effectiveness of breast cancer screening in women under 50
with a familial predisposition to this cancer. For this study we
needed information on the distribution of family histories of
breast cancer among women under the age of 50 in the general
population who might visit a healthcare doctor with concerns
about their family history of breast cancer. Several studies
have reported information on the percentage of women with
a family history of breast cancer among cases of breast cancer
and healthy controls.11 However, no such information is avail-
able for the general population. Other researchers have made
attempts to gain information on the percentage of women in
the general population who might be at an increased risk for
breast cancer by using a family history questionnaire.13 The
response rate to the questionnaire was, however, too low to
draw useful conclusions. We have chosen to simulate a general
population to gain this information.
The aim of this study was to estimate the prevalence of
family histories of breast cancer among women aged 30–50 in
the general population and to compute the incidence of
related seeking of health care.
METHODS
Design
This study was performed as part of a study on the cost effec-
tiveness of screening women under the age of 50 with a famil-
ial predisposition to breast cancer. We needed information on
the prevalence and distribution of family histories of breast
cancer among women aged 30–50 in the general population.
As this information is not directly available, we simulated data
with a model and combined them with data available from
medical publications.
Simulation of a population including prevalent breast
cancer
We simulated a population of 1 million women aged 30–50
and their first and second degree relatives, that is, sibs,
parents, maternal and paternal aunts, and uncles and grand-
parents. Third degree relatives were not included, as previous
research has shown that information on breast cancer in third
degree relatives gives little additional information on the
individual risk of breast cancer.14 The simulated pedigrees
were independent and the structures of the pedigrees were
based on actual pedigrees of 256 women under 50 years of age
who had visited our hospital in the past seven years. The Dutch
population statistics15 on age and survival were used as input
variables in the simulation model to assure that our simulated
population was comparable to the general Dutch population.
We additionally compared the simulated population and the
Dutch population for family structure, by using the mean
number of sibs as found in the simulated population and the
Dutch population.15 We found that both populations were
comparable, indicating that the 256 actual pedigrees that we
used for the simulation may be representative of general
Dutch pedigrees.
Using a genetic model,16 ancestors of the simulated
pedigrees were assigned breast cancer polymorphisms, which
were inherited by their offspring according to mendelian
rules. The genetic model was created to describe correctly
familial clustering of breast cancer by using the available
information on the two known breast cancer susceptibility
genes BRCA1 and BRCA2 from medical publications, that
is, the mutated allele frequencies17 18 and penetrance
functions.19 20 Because the BRCA1 and BRCA2 genes only
explain a small proportion of the familial clustering of breast
cancer,7 an additional gene was modelled accounting for the
remaining familial clustered breast cancer using relative risks
for breast cancer among women with relatives with breast
cancer, which were derived from a large meta-analysis.11 This
genetic model assigned the observed breast cancer incidence
Key points
• No information is available on the distribution of family
histories of breast cancer among women under the age
of 50 in the general population. In this study we
simulated a population of women aged 30–50
including their first and second degree relatives to gain
this information.
• One third of the women aged 30–50 years in the popu-
lation had at least one relative with breast cancer.
• Of the women with at least one relative with breast can-
cer, four-fifths had only second degree relatives with
breast cancer, and one-fifth had at least one first degree
relative with breast cancer.
• Most women who seek health care because of a family




in The Netherlands1 to the simulated population (fig 1), and
also provided us with information on the familial clustering of
breast cancer in the general population.
Prevalence of family histories of breast cancer
In the simulated population, the prevalence of family histories
of breast cancer was assessed. For the classification of various
risk groups for breast cancer, we determined five different
family histories for the women with at least one relative with
breast cancer (table 1). Within each of the five groups we
determined the percentage of women who had a relative with
breast cancer affected under the age of 50 and at the age of 50
or older, to define the family histories more precisely.
Incidence of related healthcare visits
To determine the incidence of seeking health care among
women with a certain family history of breast cancer, the fol-
lowing variables were abstracted from the published reports:
(1) the distribution of various family histories in general
practice and (2) the number of attendees in general practice
who newly sought health care because of a family history of
breast cancer. Two previous studies reported the variety in
family histories of breast cancer in general practice, both from
a large primary care centre which corresponded to five general
practitioner (GP) practices21 and from a sample of 200 GP
practices.22 These family histories of breast cancer were regis-
tered if a woman visited the GP with concerns about a
personal risk of breast cancer. The distribution of the various
family histories of breast cancer in general practice, as
reported by these studies, is shown in table 2. The number of
new attendees with a family history of breast cancer in
general practice was obtained through the first study: in the
five year period 1997–2001 the number of new attendees in
general practice who sought care because of their family his-
tory of breast cancer was on average 3.1/1000 women/year (SD
1.8, range 1.4–5.3) (unpublished update to De Bock et al21). In
the Dutch healthcare system, which is similar to that of the
United Kingdom, practically every person is registered with a
general practice, regardless of his or her medical condition.
People who seek care usually start at a general practice.
We computed the average, the minimum, and the maxi-
mum incidence of those seeking health care for the various
groups of women with a family history of breast cancer by
using the distribution of family histories in general practice
and the average (3.1), the minimum (1.4), and the maximum
(5.3) number of new attendees combined with the
distribution of family histories as found in our simulated
population. For each group, the incidence of those seeking
health care was proportional to the ratio of the distribution of
family histories in general practice and the distribution of
Figure 1 Age specific penetrance of breast cancer among women in the Dutch population and the simulated population.
Table 1 Family histories of breast cancer in the general population of women aged 30–50 (n=1 000 000)
No (%) No (%) No (%) No (%)
Total 1 000 000 (100.0)
Affected with breast cancer 10 166 (1.0)
Unaffected with breast cancer 989 834 (99.0) 989 834 (100.0)
And no relatives with breast cancer 643 082 (64.3)
And at least one relative with breast cancer 346 752 (34.7) 346 752 (100.0)
One 2nd and no 1st degree relatives 219 634 (22.0) 219 634 (63.3) 219 634 (100.0)
Relative was affected before 50 62 792 (28.6)
Relative was affected at or after 50 156 842 (71.4)
Two or more 2nd and no 1st degree relatives 56 018 (5.6) 56 018 (16.2) 56 018 (100.0)
At least one relative was affected before 50 32 975 (58.9)
All relatives were affected at or after 50 23 043 (41.1)
One 1st and none/one 2nd degree relatives 60 195 (6.0) 60 195 (17.4) 60 195 (100.0)
1st degree relative was affected before 50 26 490 (44.0)
1st degree relative was affected at or after 50 33 705 (56.0)
One 1st and two or more 2nd degree relatives 8 212 (0.8) 8 212 (2.4) 8 212 (100.0)
1st degree relative was affected before 50 4 180 (50.9)
1st degree relative was affected at or after 50 4 032 (49.1)
Two or more 1st degree relatives 2 693 (0.3) 2 693 (0.8) 2 693 (100.0)
At least one 1st degree relative was affected before 50 2 568 (95.4)
All 1st degree relatives were affected at or after 50 125 (4.6)
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family histories in the population, by which the sum of the
incidence of the various family history groups resulted in the
observed number of new attendees.
RESULTS
Prevalence of a family history of breast cancer
The prevalence of family histories of breast cancer in the
population of women aged 30–50 (n=1 million) is presented
in table 1. Of all the women in this population, 1.0% (n=0 166)
had breast cancer, 64.3% (n=643 082) were unaffected and
had no relatives with a history of breast cancer, and 34.7%
(n=346 752) were unaffected and had at least one relative
with breast cancer.
In the population, 12.7% of the women (n=127 118) had at
least one first degree relative or at least two second degree
relatives affected with breast cancer, of whom 55.9% (n=71
100) had at least one first degree relative with breast cancer.
Incidence of related healthcare visits
In table 2, we calculated the incidence of those seeking health
care among women with various family histories of breast
cancer. Women with one second degree relative with breast
cancer and no affected first degree relatives comprised 21.96%
of the general population and 0.8% in general practice and
their incidence of seeking health care was 0.00011 (range
0.00005–0.00018). By contrast, women with one first and two
or more second degree relatives with breast cancer or at least
two first degree relatives with breast cancer comprised 1.09%
of the general population and 16.7% in general practice and
their incidence of seeking health care was 0.04888 (range
0.02208–0.08357). Thus, the incidence of seeking health care
among women with a strong affected family history of breast
cancer is higher than of those with a less affected family his-
tory.
DISCUSSION
The present study has shown that almost 35% of the women
aged 30–50 have at least one first or one second degree relative
with breast cancer, of whom most (63.3%) only have one
affected second degree relative. In the other groups of women
with relatives with breast cancer (12.7% of all women aged
30–50) the family history of breast cancer might represent an
increased risk for the disease. The incidence of seeking health
care varies from 0.00011 among women with only one second
degree relative with breast cancer to 0.04888 among women
with one affected first degree relative and two or more second
degree relatives and women with two or more affected first
degree relatives, resulting in 3.1 new people seeking health
care/year/1000 women aged 30–50 in the population.
Some remarks on our results should be made. Firstly, we
have based our estimates on the age specific incidence of
breast cancer in The Netherlands. As this varies between
countries, the estimates could be slightly different for other
populations. Secondly, we have not included ovarian cancer or
other related cancers in the family history. This may have
resulted in an underestimation of the number of women at
increased risk, but is in line with the current guidelines for
general practice, which only include breast cancer among
family relatives.23 24 Thirdly, the number of new attendees with
a family history of breast cancer in general practice was
retrieved over a five year period from one large primary care
centre, which corresponds to five GP practices. By using a
relatively small sample of GP practices, some underestimation
of the consultation rate might be introduced. We, however,
think that these figures are representative of the general
population as other researchers found a slightly higher rate in
a sample that included women at all ages over 1625 instead of
ages 30–50 as in our population.
Our results indicate that about 13% of women aged 30–50
have at least one first degree relative or at least two second
degree relatives with breast cancer, which may relate to an
increased risk for the disease. Future studies should assess
whether screening these women or subgroups is worthwhile
and cost effective. The estimates from the current study could
be used to plan management strategies in health care for these
women and to compute the cost effectiveness of various treat-
ment strategies in this subgroup of women. In addition, future
studies should also be directed at gaining insight into the sen-
sitivity and specificity of preventive strategies for women
under the age of 50 to decide if the currently available preven-
tive strategies are effective in these women.
In conclusion, about 13% of the women aged 30–50 have a
family history of breast cancer that may relate to an increased
risk for breast cancer and most of the women who seek health
care because of a family history of breast cancer are those
women who have higher risk pedigrees. The estimates that we
provided may be used in future studies that investigate man-
agement strategies and compute the cost effectiveness of
monitoring women aged 30–50 who might be at an increased
risk for breast cancer.
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general practice21 22 (%)
Incidence of seeking health care
Minimum Mean Maximum
New attendees in health care relating to a family history of
breast cancer (n/1000 women aged 30–5021)
1.4 3.1 5.3
One 2nd degree relative 21.96 0.8 0.00005 0.00011 0.00018
Two or more 2nd degree relatives 5.60 14.5 0.00362 0.00802 0.01371
One 1st and no/one 2nd degree relative; 1st >50 at onset 3.37 31.8 0.01324 0.02932 0.05013
One 1st and no/one 2nd degree relative; 1st <50 at onset 2.65 36.2 0.01937 0.04288 0.07331
One 1st and >two 2nd degree relatives or >two 1st degree
relatives
1.09 16.7 0.02208 0.04888 0.08357
Total 34.68 100.00
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